
MONDAY, Sept. 23, 2019 Low-dose aspirin may improve survival odds for patients battling head/neck and lung cancer, two new studies suggest. The first reviewed data on 460 patients with head and neck squamous cell carcinoma (HNSCC) or early stage non-small cell lung cancer (NSCLC). That study concluded that taking a non-steroidal anti-inflammatory drug such as… read on >